Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06295211
Status:
COMPLETED
Last Update Posted:
2024-03-06
First Post:
2024-02-23
Brief Title:
Brentuximab Vedotin Combined With Bendamustine Supercharge a Low-toxicity and Efficient Salvage Regimen for Primary Refractory or First-relapsed Classic Hodgkin Lymphoma Long-term Results of a Retrospective Monocenter Study
Sponsor:
Federico II University
Organization:
Federico II University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-22
Completion Date Type:
ACTUAL
First Submit Date:
2024-02-23
First Submit QC Date:
March 3 2024
Study First Post Date:
2024-03-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-03
Last Update Post Date:
2024-03-06
Last Update Post Date Type:
ACTUAL